Muehler Andreas 4
4 · IMMUNIC, INC. · Filed May 16, 2022
Insider Transaction Report
Form 4
IMMUNIC, INC.IMUX
Muehler Andreas
Chief Medical Officer
Transactions
- Purchase
Common Stock
2022-05-12$5.10/sh+3,500$17,850→ 297,986 total
Footnotes (1)
- [F1]Consists of 13,506 shares of common stock held directly by the Reporting Person and 284,480 shares of common stock held indirectly by Xanomed GmbH, an entity controlled by the Reporting Person.